(Q70733006)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8500219%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

title

Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8500219%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

1 reference

1 reference

T Shirasaka

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8500219%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

Y Shimamoto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8500219%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

H Ohshimo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8500219%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

H Saito

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8500219%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

M Fukushima

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8500219%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8500219%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

13 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8500219%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8500219%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8500219%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

page(s)

167-172

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8500219%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00685830

13 October 2019

exact match

0 references

cites work

Inhibitory effects of pyrimidine, barbituric acid and pyridine derivatives on 5-fluorouracil degradation in rat liver extracts

1 reference

12 December 2020

Effect of 5-fluorouracil on the synthesis and translation of polyadenylic acid-containing RNA from regenerating rat liver

1 reference

12 December 2020

Pilot trial of prolonged continuous-infusion 5-fluorouracil and weekly cisplatin in advanced colorectal cancer

1 reference

12 December 2020

Mechanisms of innate resistance to thymidylate synthase inhibition after 5-fluorouracil

1 reference

12 December 2020

Continuous Infusion or Bolus Injection in Cancer Chemotherapy

1 reference

12 December 2020

Phase II trial of carboplatin and tegafur (Ftorafur) as induction therapy in squamous-cell carcinoma of the head and neck

1 reference

12 December 2020

Effect of uracil and its derivatives on antitumor activity of 5-fluorouracil and 1-(2-tetrahydrofuryl)-5-fluorouracil

1 reference

12 December 2020

Evaluation of high-dose cisplatin and 5-FU infusion as initial therapy in advanced head and neck cancer

1 reference

12 December 2020

Clinical basis of chemotherapy for gastric cancer with uracil and 1-(2'-tetrahydrofuryl)-5-fluorouracil

1 reference

12 December 2020

Differentiation of DNA-platinum complexes by fluorescence. The use of an intercalating dye as a probe

1 reference

12 December 2020

Thymidylate synthetase: mechanism of inhibition by 5-fluoro-2'-deoxyuridylate.

1 reference

12 December 2020

Effects of 5-FU and cis-DDP combination on human colorectal tumor xenografts

1 reference

12 December 2020

Superior clinical response and survival rates with initial bolus of cisplatin and 120 hour infusion of 5-fluorouracil before definitive therapy for locally advanced head and neck cancer

1 reference

12 December 2020

Response rates and survival in patients with head and neck cancer treated with a combination of cisplatin and 5-fluorouracil prior to radiotherapy

1 reference

12 December 2020

Phosphorus compounds in animal tissues; a comparison of methods for the estimation of nucleic acids

1 reference

12 December 2020

Sequence dependence of the antitumor and toxic effects of 5-fluorouracil and cis-diamminedichloroplatinum combination on primary colon tumors in mice

1 reference

12 December 2020

Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells

1 reference

12 December 2020

Cisplatin bolus and 5-FU infusion chemotherapy for non-small cell lung cancer

1 reference

12 December 2020

Effects of the plasma concentration of 5-fluorouracil and the duration of continuous venous infusion of 5-fluorouracil with an inhibitor of 5-fluorouracil degradation on Yoshida sarcomas in rats.

1 reference

12 December 2020

Postgastrectomy prescription of mitomycin C and UFT for patients with stage IV gastric carcinoma

1 reference

12 December 2020

Studies on fluorinated pyrimidines. XIII. Inhibition of thymidylate synthetase.

1 reference

12 December 2020

The clinical effects of the continuous administration of fluorinated pyrimidines (5-fluorouracil and 5-fluoro-2'-deoxyuridine)

1 reference

12 December 2020

A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study

1 reference

12 December 2020

In vivo kinetics of thymidylate synthetase inhibition of 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas.

1 reference

12 December 2020

The inhibition of ribosomal RNA synthesis and maturation in Novikoff hepatoma cells by 5-fluorouridine

1 reference

12 December 2020

Phase II trial of cisplatin and tegafur (Ftorafur) as initial therapy in squamous-cell carcinoma of the head and neck

1 reference

12 December 2020

Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil.

1 reference

12 December 2020

5-Fluoro-2′-Deoxyuridylate: Covalent Complex with Thymidylate Synthetase

1 reference

12 December 2020

Results of a phase II study of the combination of cis-platinum and 5-FU in epidermoid or undifferentiated large cell bronchial cancer

1 reference

12 December 2020

Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma

1 reference

12 December 2020

The regulation of folate and methionine metabolism

1 reference

12 December 2020

Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin.

1 reference

12 December 2020

Neoadjuvant therapy for advanced head and neck cancer with allopurinol-modulated high dose 5-fluorouracil and cisplatin. A phase I-II study

1 reference

12 December 2020

Inhibition of amino acid transport by cis-diamminedichloroplatinum(II) derivatives in L1210 murine leukemia cells

1 reference

12 December 2020

Low-dose continuous infusion 5-fluorouracil and cisplatin: phase II evaluation in advanced colorectal carcinoma.

1 reference

12 December 2020

Comparison of folylpolyglutamate hydrolases of mouse liver, kidney, muscle and brain

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00685830

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8500219%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

1 reference